Kinetics of insulin-like growth factor (IGF) and IGF-binding protein responses to a single dose of growth hormone

The effect of 30-m repeated sprint exercise on muscle damage indicators, serum insulin-like growth factor-Iand cortisol

Study aim: The purpose of this study was to examine the effects of arepeated sprint exercise protocol on muscle damage indicators, serum IGF-Iand cortisol levels.

Material and methods: Nine trained male subjects (age 23.3 ± 3.6 years) completed arepeated sprint protocol consisting of two sets of 10 × 30-m maximal sprints with 30 s of active recovery between sprints and 5 min of passive recovery between sets. The isometric strength and flexibility were measured before, immediately after and 24 hours after exercise. 30-m maximal sprint time was measured before and 24 hours after exercise. Blood samples were taken before, immediately after and 24 hours after exercise.

Results: Isometric strength and flexibility were significantly decreased after exercise and 24 hours after exercise (p < 0.05). 30-m sprint time was significantly increased 24 hours after exercise (p < 0.05). Asignificant increase in serum lactate dehydrogenase, IGF-Iand cortisol were found after exercise (p < 0.05). Serum creatine kinase increased significantly immediately after and 24 hours after exercise compared to pre-exercise values (p < 0.05).

Conclusion: Our data show that due to increased serum IGF-Ilevel, repeated sprint exercise may have anabolic effects as well as traumatic effects on the muscles.

Control of IGFBP-2 Expression by Steroids and Peptide Hormones in Vertebrates

IGFBP-2 (1) has been described as a brain tumor oncogene (2) and is widely expressed in cancers from different origins (3-8). IGFBP-2 alone cannot cause malignant transformation, yet progression of brain tumors to higher grade (9) and also has been provided as a protective element in earlier stages of multistage colon carcinogenesis (10). Therefore, it is crucial to understand the factors that determine expression patterns of IGFBP-2 under normal and malignant conditions. The present review provides a comprehensive update of known factors that have an impact on expression of IGFBP-2.